Lite Strategy Inc
Research Lite Strategy Inc (LITS) on Bullrun: market cap USD 41.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLITS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 41.51M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 23.69M
- Free cash flow-USD 1.52M
Valuation Snapshot
latest market cap is USD 41.51M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 15.95M | -USD 20.84M | n/a | -2.39 | USD 18.01M | n/a | USD 16.93M |
| FY2024 | USD 65.30M | USD 17.78M | -USD 50.48M | n/a | 2.67 | USD 3.71M | USD 0 | USD 33.02M |
| FY2023 | USD 48.82M | -USD 32.00M | -USD 52.52M | n/a | -4.78 | USD 16.91M | USD 12.73M | USD 24.62M |
| FY2022 | USD 40.70M | -USD 54.00M | -USD 49.23M | 100.0% | -9.99 | USD 15.74M | USD 9.64M | USD 52.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 41.51M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 48.56M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 16.39M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 38.64M | 0.9 | 30.2% | 1.75 |
| 2022 | 2022-12-30 | USD 31.98M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 354.86M | n/a | n/a | n/a |
Dividend history
| Year | Dividends/share |
|---|---|
| FY2024 | 1.75 USD |
| FY2023 | 1.75 USD |
About Lite Strategy Inc
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lite Strategy Inc's market cap?
Lite Strategy Inc's market capitalization is USD 41.51M.
What does Lite Strategy Inc do?
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.